Second-line treatment of hepatocellular carcinoma: from theory to practical issues

by V. V. Breder, K. K. Laktionov
Published 2019-12-01

Ceritinib in the treatment of ALK-positive patients with nonsmall-cell lung cancer

by K. K. Laktionov, E. V. Reutova
Published 2019-06-01

Immunotherapy for hepatocellular cancer: beginning and future perspectives

by M. A. Kazantseva, V. V. Breder, K. K. Laktionov
Published 2019-06-01

PHARMACOLOGICAL THERAPY OF HEPATOCELLULAR CANCER PRACTICAL ISSUES AND SOLUTIONS

by V. V. Breder, K. K. Laktionov, M. I. Davydov
Published 2017-11-01

Rational approach to the treatment of EGFR-positive lung cancer

by E. V. Reutova, K. K. Laktionov, D. I. Yudin, M. S. Ardzinba
Published 2019-12-01

TARGETED THERAPY OF LUNG CANCER WITH THE ROS1 REARRANGEMENT

by K. K. LAKTIONOV, E. V. REUTOVA, M. S. ARDZINBA, N. A. MESCHERYAKOVA
Published 2017-06-01

Immunotherapy for small-cell lung cancer

by A. Ye. Kuzminov, K. K. Laktionov, A. A. Yegorova, V. V. Breder, T. D. Barbolina
Published 2019-06-01

Oncological care for the patients with hepatocellular carcinoma in COVID-19 pandemic

by V. V. Petkau, V. V. Breder, E. N. Bessonova, K. K. Laktionov, I. S. Stilidi
Published 2020-07-01

Prospects for the development of adjuvant therapy for non-small cell lung cancer

by K. K. Laktionov, A. M. Kazakov, E. V. Reutova, M. S. Ardzinba, A. L. Arzumanian
Published 2020-11-01

Clinical case of use of osimertinib in a patient with disseminated EGFR-mutated non-small cell lung cancer in the first-line therapy

by K. A. Sarantseva, K. K. Laktionov, E. V. Reutova, D. I. Yudin, V. V. Breder
Published 2020-12-01

Firsthand experience of chemoradiotherapy in patients with localized small cell lung cancer. Retrospective assessment

by A. E. Kuzminov, T. N. Borisova, V. V. Breder, E. V. Reutova, T. D. Barbolina, K. K. Laktionov
Published 2020-07-01

The first experience of immunotherapy application of ipilimumab in combination with chemotherapy of small-cell lung cancer in the Russian population. Analysis of the combined data...

by A E Kuzminov, V A Gorbunova, E V Poddubskaya, S G Bagrova, M P Baranova, K K Laktionov
Published 2018-09-01

Three-year results of application of nivolumab in patients with non-small cell lung cancer in clinical practice of the N.N. Blokhin Russian Cancer Research Center

by K. K. Laktionov, K. A. Sarantseva, D. I. Yudin, V. V. Breder, E. V. Reutova, K. P. Laktionov
Published 2019-12-01

Fibrolamellar liver cancer: the modern concept

by E. Yu. Antonova, V. V. Breder, E. A. Moroz, K. K. Laktionov, I. A. Dzhanyan, A. Yu. Volkov
Published 2020-12-01

A clinical case of 3-year highly efficient pembrolizamable therapy of metasatic lung adenocarcinoma

by K. K. Laktionov, D. I. Yudin, K. A. Sarantseva, K. P. Laktionov, V. V. Breder, E. V. Reutova
Published 2018-07-01

BCLC-B hepatocellular carcinoma treatment or when should the systemic therapy be started

by V. V. Breder, M. U. Pitkevich, E. R. Virshke, L. A. Kostyakova, I. A. Dzhanyan, K. K. Laktionov
Published 2018-07-01

A case report of immune-related pneumonitis after combined treatment of non small cell lung cancer

by E. S. Denisova, M. S. Ardzinba, K. K. Laktionov, D. I. Yudin, K. A. Sarantseva, G. V. Shcherbakova, N. V. Marinichenko
Published 2020-07-01

Abscopal effect in a patient with metastatic NSCLC following a course of radiation therapy to the brain

by E. S. Denisova, K. K. Laktionov, T. N. Borisova, Merab. S. Ardzinba, A. A. Fedorova, D. I. Yudin, S. S. Magamedova, Milada A. Ardzinba
Published 2020-12-01

Pseudoprogression in patients on immunotherapy

by D. I. Yudin, K. K. Laktionov, K. A. Sarantseva, V. V. Breder, E. V. Reutova, O. I. Borisova, M. S. Ardzinba
Published 2019-06-01

Phenotypic transformation as a cause of secondary drug resistance to osimetinib clinical observation

by L. A. Nelyubina, E. V. Reutova, K. K. Laktionov, D. I. Yudin, D. T. Marinov, E. N. Kozak, V. V. Mochalnikova
Published 2018-11-01